Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Production and Sales of Pharmaceutical Raw Materials	463.72M	447.58M	442.87M	420.89M	367.06M
Production and Sales of Pharmaceutical Raw Materials Growth	3.60%	1.07%	5.22%	14.67%	18.02%
Total	463.72M	447.58M	442.87M	420.89M	367.06M
Total Growth	3.60%	1.07%	5.22%	14.67%	18.02%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Overseas	66.27M	97.55M	96.22M	68.74M	49.74M
Overseas Growth	-32.07%	1.38%	39.98%	38.19%	-7.86%
East China	187.05M	149.99M	202.29M	182.89M	152.29M
East China Growth	24.71%	-25.86%	10.60%	20.10%	35.69%
North China	127.80M	123.90M	71.44M	53.98M	54.07M
North China Growth	3.14%	73.45%	32.35%	-0.17%	21.37%
Central China	23.49M	17.07M	14.00M	33.03M	44.92M
Central China Growth	37.63%	21.89%	-57.61%	-26.47%	-4.80%
Southwest	35.37M	30.15M	24.79M	27.58M	31.07M
Southwest Growth	17.35%	21.60%	-10.12%	-11.21%	82.75%
South China	11.27M	15.85M	24.58M	44.16M	21.85M
South China Growth	-28.92%	-35.52%	-44.33%	102.08%	-14.76%
Northeast	7.74M	7.88M	8.39M	9.13M	10.21M
Northeast Growth	-1.79%	-6.10%	-8.07%	-10.58%	40.29%
Northwest	4.73M	5.19M	1.15M	1.37M	1.80M
Northwest Growth	-8.95%	352.38%	-16.30%	-23.83%	-12.52%
Total	463.72M	447.58M	442.87M	420.89M	365.95M
Total Growth	3.60%	1.07%	5.22%	15.01%	18.08%

Source: S&P Global Market Intelligence.